Advantages of treatment with Reprimun in sarcoidosis.
Favourable results were obtained by treatment with Reprimun alone or in association with low doses of Prednisone in 112 patients with sarcoidosis (59% with active sarcoidosis and 33% failures of a previous corticotherapy). Treatments were applied during 3-6 series each one of 6 weeks at intervals of 2 weeks between series. In comparison with the classical corticotherapy, treatment with Reprimun has better results, namely: absence of any major adverse reactions; reduction of the treatment period to 6-12 months (3-6 series); 95% lasting remissions in the sarcoidoses with initial treatment and 78% remissions in the case of failures of a previous corticotherapy.
Păunescu
E
E
Tuberculosis Research Institute, Bucharest, Romania.
Didilescu
C
C
Mihălţan
F
F
Udrea
S
S
Serbescu
A
A
Dănălache-Dumitrescu
M
M
Smărăndache
M
M
Stoinescu
M
M
Zaharescu
C
C
Petre
A
A
D000293:Adolescent; D000328:Adult; D002648:Child; D004341:Drug Evaluation; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D008171:Lung Diseases / Q000188:drug therapy*; D008297:Male; D008477:Mediastinal Diseases / Q000188:drug therapy*; D008875:Middle Aged; D011241:Prednisone / Q000627:therapeutic use*; D012074:Remission Induction; D012294:Rifamycins / Q000627:therapeutic use*; D012507:Sarcoidosis / Q000188:drug therapy*
D012294:Rifamycins; C062637:Reprimun; D011241:Prednisone